These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10366321)

  • 1. Prophylactic mastectomy in women with a high risk of breast cancer.
    Kuerer HM; Hwang ES; Esserman LJ
    N Engl J Med; 1999 Jun; 340(23):1838; author reply 1839. PubMed ID: 10366321
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's health insurance coverage in California.
    Wyn R
    Policy Brief UCLA Cent Health Policy Res; 2006 Nov; (PB2006-7):1-4. PubMed ID: 17152143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family income and health insurance coverage for women in California.
    Wyn R; Pourat N
    Policy Brief UCLA Cent Health Policy Res; 1997 Jun; (PB 97-4):1-4. PubMed ID: 11475520
    [No Abstract]   [Full Text] [Related]  

  • 6. Insurance policies for prophylactic surgery: to cover or not to cover?
    Morrow M
    Ann Surg Oncol; 2000 Jun; 7(5):321-2. PubMed ID: 10864336
    [No Abstract]   [Full Text] [Related]  

  • 7. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
    Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
    J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current national health insurance policies for thyroid cancer prophylactic surgery in the United States.
    Dackiw AP; Kuerer HM; Clark OH
    World J Surg; 2002 Aug; 26(8):903-6. PubMed ID: 12045864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Clark K
    J Insur Med; 1999; 31(1):41-3. PubMed ID: 10539391
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic mastectomy.
    Zakaria S; Degnim AC
    Surg Clin North Am; 2007 Apr; 87(2):317-31, viii. PubMed ID: 17498529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
    J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient mastectomy: clinical, payer, and geographic influences.
    Case C; Johantgen M; Steiner C
    Health Serv Res; 2001 Oct; 36(5):869-84. PubMed ID: 11666108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.
    Hsia J; Kemper E; Kiefe C; Zapka J; Sofaer S; Pettinger M; Bowen D; Limacher M; Lillington L; Mason E
    Prev Med; 2000 Sep; 31(3):261-70. PubMed ID: 10964640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lesser evil: prophylactic mastectomy for women at high risk for breast cancer.
    Schover LR
    J Clin Oncol; 2008 Aug; 26(24):3918-9. PubMed ID: 18711178
    [No Abstract]   [Full Text] [Related]  

  • 20. Bilateral prophylactic mastectomy in women with an increased risk of breast cancer.
    Tecnologica MAP Suppl; 1999 Jun; ():3-6. PubMed ID: 10848037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.